Complete Response After Imatinib Mesylate Therapy in a Patient With Well-Differentiated Systemic Mastocytosis

被引：57

作者：

Alvarez-Twose, Ivan ^{[1
]}

Gonzalez, Pablo ^{[2
]}

机构：

[1] Hosp Virgen Valle, Inst Estudios Mastocitosis Castilla La Mancha, Toledo, Spain

[2] Hosp Virgen Nieves, Granada, Spain

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 12期

关键词：

IDIOPATHIC HYPEREOSINOPHILIC SYNDROME; GASTROINTESTINAL STROMAL TUMORS; CHRONIC MYELOID-LEUKEMIA; KINASE INHIBITOR STI571; ABL TYROSINE KINASE; MAST-CELL DISEASE; C-KIT MUTATION; WILD-TYPE; CUTANEOUS MASTOCYTOSIS; RESISTANT;

D O I：

10.1200/JCO.2011.38.9973

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E126 / E129

页数：4

共 35 条

[1] A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib [J].

Akin, C ;

Fumo, G ;

Yavuz, AS ;

Lipsky, PE ;

Neckers, L ;

Metcalfe, DD .

BLOOD, 2004, 103 (08) :3222-3225

[2]

Akin C., 2004, Journal of Allergy and Clinical Immunology, V113, pS327, DOI 10.1016/j.jaci.2004.01.683

[3] Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit [J].

Akin, C ;

Brockow, K ;

D'Ambrosio, C ;

Kirshenbaum, AS ;

Ma, YS ;

Longley, BJ ;

Metcalfe, DD .

EXPERIMENTAL HEMATOLOGY, 2003, 31 (08) :686-692

[4] Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate [J].

Ault, P ;

Cortes, J ;

Koller, C ;

Kaled, ES ;

Kantarjian, H .

LEUKEMIA RESEARCH, 2002, 26 (09) :881-884

[5] Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome [J].

Cortes, J ;

Ault, P ;

Koller, C ;

Thomas, D ;

Ferrajoli, A ;

Wierda, W ;

Rios, MB ;

Letvak, L ;

Kaled, ES ;

Kantarjian, H .

BLOOD, 2003, 101 (12) :4714-4716

[6] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].

Demetri, GD ;

von Mehren, M ;

Blanke, CD ;

Van den Abbeele, AD ;

Eisenberg, B ;

Roberts, PJ ;

Heinrich, MC ;

Tuveson, DA ;

Singer, S ;

Janicek, M ;

Fletcher, JA ;

Silverman, SG ;

Silberman, SL ;

Capdeville, R ;

Kiese, B ;

Peng, B ;

Dimitrijevic, S ;

Druker, BJ ;

Corless, C ;

Fletcher, CDM ;

Joensuu, H .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480

[7] Imatinib mesylate in the treatment of systemic mastocytosis - A phase II trial [J].

Droogendijk, Helga J. ;

Kluin-Nelemans, Hanneke J. C. ;

van Doormaal, Jaap J. ;

Oranje, Arnold R. ;

van de Loosdrecht, Arjan A. ;

van Daele, Paul L. A. .

CANCER, 2006, 107 (02) :345-351

[8] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].

Druker, BJ ;

Sawyers, CL ;

Kantarjian, H ;

Resta, DJ ;

Reese, SF ;

Ford, JM ;

Capdeville, R ;

Talpaz, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042

[9] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[10] Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients [J].

Escribano, Luis ;

Alvarez-Twose, Ivan ;

Sanchez-Munoz, Laura ;

Garcia-Montero, Andres ;

Nunez, Rosa ;

Almeida, Julia ;

Jara-Acevedo, Maria ;

Teodosio, Cristina ;

Garcia-Cosio, Monica ;

Bellas, Carmen ;

Orfao, Alberto .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (03) :514-521

← 1 2 3 4 →